Tiziana Life Sciences Ltd

TLSA Healthcare Biotechnology

Insiders bought in the last twelve months.

1.06 0.01 +0.95%
Market cap
$134.7M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
4.01 3.72 1.18 18.12 42.19 65.82 0.20 5.30 0.06 5.80
Receivables
4.08 3.64 5.93 5.86 5.19 3.57 1.14 1.04 2.78 0.14
Total current assets
8.55 7.51 7.34 24.28 48.68 70.18 1.51 6.91 2.45 6.20
Property, Plant, Equpment (Net)
0.03 0.02 0.01 0.02 0.02 0.00 0.01 0.01 0.02 0.04
Long-Term Investments
2.44 3.59 4.55 1.81 — — — — — —
Long-term receivables
— — — — — 0.12 0.15 — — —
Goodwill and Intangible Assets (Total)
— — — — 0.13 0.13 — — — —
Long-term assets (Other)
— — — — — — 0.29 0.35 — —
Total non-current assets
2.94 3.78 4.85 2.20 0.15 0.49 0.87 0.01 0.02 0.04
Total Assets
11.50 11.28 12.18 26.48 48.83 70.66 2.38 6.92 2.47 6.23
Accounts Payable
10.46 7.23 6.39 6.53 6.18 5.59 6.40 5.95 4.75 2.14
Current Part of Debt
— — — — — 0.32 1.16 0.57 0.43 0.34
Current Revenue (Deferred)
0.53 — — — — — — — — —
Other current liabilities
0.00 0.01 0.01 0.01 0.01 0.09 0.08 7.63 6.00 2.31
Total current liabilities
11.21 7.35 6.54 6.66 7.55 7.98 7.35 6.40 4.75 2.14
Total non-current liabilities
0.23 — 0.11 0.24 — 0.29 0.54 — — —
Total liabilities
11.44 7.35 6.65 6.91 7.55 8.27 7.89 6.40 4.75 2.14
Additional Paid In Capital
34.66 23.11 16.49 15.60 15.60 111.82 39.93 39.83 31.28 8.94
Common Stock (Net)
0.12 0.11 0.10 0.10 0.10 0.10 8.60 8.59 8.14 6.90
Retained Earnings
(163.11) (144.83) (133.68) (116.26) (108.06) (84.65) (60.04) (50.72) (42.61) (29.73)
Treasury Stock
— — 1.57 1.32 — — — — — —
Shareholders Equity (Other)
128.38 125.55 124.19 121.46 133.65 146.94 6.00 2.82 0.91 17.97
Common Equity (Total)
0.05 3.94 5.54 19.57 41.28 62.39 (5.51) 0.52 (2.28) 4.09
Shareholders Equity (Total)
0.05 3.94 5.54 19.57 41.28 62.39 (5.51) 0.52 (2.28) 4.09
Shareholders Equity and Liabilities (Total)
11.50 11.28 12.18 26.48 48.83 70.66 2.38 6.92 2.47 6.23
Shares (Common)
120.51 111.46 103.09 102.27 102.27 97.31 27.33 68.23 62.53 47.20
Shareholders Equity (Tangible)
0.05 3.94 5.54 19.57 41.15 62.26 (5.51) 0.52 (2.28) 4.09
Net Debt
(4.01) (3.72) (1.18) (18.12) (42.19) (65.50) 0.96 (4.73) 0.36 (5.46)
Total Debt
— — — 0.15 1.83 0.32 1.16 0.57 0.43 0.34

Fold the line items

In millions of $ except per-share values · columns are period end dates